Ocrevus Injection Now Affordable for MS Patients
Update: 2025-12-04
Description
Ocrevus, a groundbreaking injection treatment for multiple sclerosis, is now listed on Australias Pharmaceutical Benefits Scheme, significantly reducing its cost from over sixteen thousand dollars to just thirty-one dollars and sixty cents. This change is particularly significant as Ocrevus is the first twice-yearly injection approved in Australia that helps slow down the progression of physical disability and reduces relapses for people with relapsing-remitting multiple sclerosis. Ash Irwin, a former My Kitchen Rules contestant and multiple sclerosis patient, shares her experience and welcomes the new, quick injection as a game-changer for busy individuals. Federal Health Minister Mark Butler emphasizes this new listing as part of the governments commitment to making medicines more affordable and accessible for all Australians.
The Daily News Now! - Every city. Every story. Powered by AI.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
